Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,204) with videos related to
Page
of 121
Sort By:
Oncotarget
|
September 17, 2016
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
Julian C Bahr, Robert W Robey, Victoria Luchenko, et al.
Leukemia & Lymphoma
|
September 21, 2025
From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes
Alexander Kaminsky, Lauren M Fahmy, Zaid Bilgrami, et al.
Ebiomedicine
|
August 24, 2024
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses
Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, et al.
Cancers
|
July 29, 2025
Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment
Andrew V Kossenkov, Noor Dawany, Sonali Majumdar, et al.
Advances in Radiation Oncology
|
February 2, 2024
Effects of Wildfire Events on California Radiation Oncology Clinics and Patients
Katie E Lichter, Claire C Baniel, Isabelle Do, et al.
Journal of Clinical Pharmacology
|
December 5, 2015
UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation
Cody J Peer, Andrew K L Goey, Tristan M Sissung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma
Sukyung Woo, Erin R Gardner, Xiaohong Chen, et al.
Iscience
|
March 5, 2021
Sox2 modulation increases naïve pluripotency plasticity
Kathryn C Tremble, Giuliano G Stirparo, Lawrence E Bates, et al.
Nature Ecology & Evolution
|
April 22, 2022
Anthropogenic disruptions to longstanding patterns of trophic-size structure in vertebrates
Rob Cooke, William Gearty, Abbie S A Chapman, et al.
The Oncologist
|
March 15, 2012
A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors
Ronan J Kelly, Robert W Robey, Clara C Chen, et al.
Page
of 121
Search research articles
Search
Showing results (1041-1050 of 1,204) with videos related to
Sort By:
Page
of 121
Oncotarget
|
September 17, 2016
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
Julian C Bahr, Robert W Robey, Victoria Luchenko, et al.
Leukemia & Lymphoma
|
September 21, 2025
From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes
Alexander Kaminsky, Lauren M Fahmy, Zaid Bilgrami, et al.
Ebiomedicine
|
August 24, 2024
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses
Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, et al.
Cancers
|
July 29, 2025
Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment
Andrew V Kossenkov, Noor Dawany, Sonali Majumdar, et al.
Advances in Radiation Oncology
|
February 2, 2024
Effects of Wildfire Events on California Radiation Oncology Clinics and Patients
Katie E Lichter, Claire C Baniel, Isabelle Do, et al.
Journal of Clinical Pharmacology
|
December 5, 2015
UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation
Cody J Peer, Andrew K L Goey, Tristan M Sissung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma
Sukyung Woo, Erin R Gardner, Xiaohong Chen, et al.
Iscience
|
March 5, 2021
Sox2 modulation increases naïve pluripotency plasticity
Kathryn C Tremble, Giuliano G Stirparo, Lawrence E Bates, et al.
Nature Ecology & Evolution
|
April 22, 2022
Anthropogenic disruptions to longstanding patterns of trophic-size structure in vertebrates
Rob Cooke, William Gearty, Abbie S A Chapman, et al.
The Oncologist
|
March 15, 2012
A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors
Ronan J Kelly, Robert W Robey, Clara C Chen, et al.
Page
of 121